Fundraising FoxMBX Capital — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Founder)inDr. David Suhy(Co-founder & Chief Scientific Officer)
BoardJustin Kao(Director)inJorge Conde(Director)in
Co-investorsAlumni VenturesAndreessen HorowitzBlue Ivy VenturesBreyer CapitalGaingelsHan River Partners+6 more
__Twitter.png)
ixlayer provides a platform that connects biopharma companies with patients, labs, providers, and payment systems to deploy personalized patient experience programs powered by AI.
AI & Machine LearningDigital HealthHealthtechSaaS
Pouria Sanae(Founder)inPoorya Sabounchi(Co-founder and Chief Operating Officer)in
Co-investorsBIOSPRING PARTNERSInitiate Venture PartnersNimble PartnersPlug and Play VenturesXYZ Venture CapitalGeneral Catalyst
.png)
Psychedelic therapies for addiction.
BiotechSan Francisco, US
Jeeshan Chowdhury(Executive Officer, Director, Promoter)in
BoardSam Altman(Director)inKrishna Kantheti(Director)
Co-investorsAPOLLO PROJECTSLIONHEART VENTURESUprising
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.